MA24643A1 - Tetrahydro-naphtalenes substitues et composes analogues - Google Patents

Tetrahydro-naphtalenes substitues et composes analogues

Info

Publication number
MA24643A1
MA24643A1 MA25245A MA25245A MA24643A1 MA 24643 A1 MA24643 A1 MA 24643A1 MA 25245 A MA25245 A MA 25245A MA 25245 A MA25245 A MA 25245A MA 24643 A1 MA24643 A1 MA 24643A1
Authority
MA
Morocco
Prior art keywords
naphthalenes
substituted tetrahydro
similar compounds
compounds
pharmaceuticals
Prior art date
Application number
MA25245A
Other languages
English (en)
Inventor
Bremm Klaus-Dieter
Schmidt Gunter
Brandes Arndt
Schmidt Delf
Naab Paul
Stoltefub Jurgen
Logers Michael
Bischoff Hilmar
Schmeck Carsten
Paulsen Holger
Antons Stefan
Nicholas Muller Stephan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19832159A external-priority patent/DE19832159A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA24643A1 publication Critical patent/MA24643A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/18Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA25245A 1997-09-18 1998-09-08 Tetrahydro-naphtalenes substitues et composes analogues MA24643A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19741050 1997-09-18
DE19832159A DE19832159A1 (de) 1997-09-18 1998-07-17 Substituierte Tetrahydro-naphthaline

Publications (1)

Publication Number Publication Date
MA24643A1 true MA24643A1 (fr) 1999-04-01

Family

ID=26040079

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25245A MA24643A1 (fr) 1997-09-18 1998-09-08 Tetrahydro-naphtalenes substitues et composes analogues

Country Status (9)

Country Link
US (1) US6586613B1 (fr)
EP (1) EP1017659B1 (fr)
JP (1) JP2001516732A (fr)
AT (1) ATE294152T1 (fr)
AU (1) AU9744298A (fr)
ES (1) ES2242302T3 (fr)
MA (1) MA24643A1 (fr)
PT (1) PT1017659E (fr)
WO (1) WO1999014174A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
WO2000038721A1 (fr) 1998-12-23 2000-07-06 G.D. Searle Llc Combinaisons d'inhibiteurs de la proteine de transfert du cholesteryle-ester et de derives de l'acide nicotinique utilisees dans le cadre de troubles cardio-vasculaires
DE19935966A1 (de) * 1999-07-30 2001-02-01 Bayer Ag Verfahren zur Reduktion von Ketoalkoholen
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
EP1269994A3 (fr) 2001-06-22 2003-02-12 Pfizer Products Inc. Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament
OA12625A (en) 2001-06-22 2006-06-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug.
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
FR2832919B1 (fr) 2001-12-04 2004-02-20 Imv Technologies Seringue d'injection du contenu d'une paillette pour l'insemination artificielle d'un animal ou le transfert embryonnaire
IL162533A0 (en) 2001-12-19 2005-11-20 Atherogenics Inc Chalcone derivatives and their use to treat diseases
WO2003053359A2 (fr) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
US6852753B2 (en) 2002-01-17 2005-02-08 Pharmacia Corporation Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
JP2006513186A (ja) 2002-12-20 2006-04-20 ファイザー・プロダクツ・インク Cetp阻害剤およびhmg−coaレダクターゼ阻害剤を含む剤形
PT1603553E (pt) 2003-03-17 2012-02-03 Japan Tobacco Inc Composições farmacêuticas de inibidores de cetp
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
MXPA06003357A (es) * 2003-09-26 2006-06-08 Japan Tobacco Inc Metodo para inhibir la produccion de lipoproteina remanente.
ES2384980T3 (es) * 2004-12-18 2012-07-16 Bayer Pharma Aktiengesellschaft Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos
WO2006082518A1 (fr) 2005-02-03 2006-08-10 Pfizer Products Inc. Compositions pharmaceutiques a efficacite amelioree
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
JP2009512715A (ja) 2005-10-21 2009-03-26 ノバルティス アクチエンゲゼルシャフト レニン阻害剤と抗異脂肪血症剤および/または抗肥満症剤の組み合わせ
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
BRPI0909105A2 (pt) * 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
EP2379547A1 (fr) 2008-12-16 2011-10-26 Schering Corporation Dérivés de pyridopyrimidine et leurs procédés d'utilisation
CA2804924C (fr) 2010-07-09 2016-06-28 Daiichi Sankyo Company, Limited Compose de pyridine substitue
JP6742316B2 (ja) 2014-09-09 2020-08-19 ベーリンガー インゲルハイム インターナショナル トレイディング (シャンハイ) カンパニー リミテッド スピロ[2.5]オクタン−5,7−ジオンおよびスピロ[3.5]ノナン−6,8−ジオンの調製のための新規なプロセス

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5446207A (en) 1993-09-01 1995-08-29 Harbor Branch Oceanographic Institution, Inc. Anti-dyslipidemic agents
HRP970330B1 (en) 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines

Also Published As

Publication number Publication date
EP1017659A1 (fr) 2000-07-12
ATE294152T1 (de) 2005-05-15
WO1999014174A1 (fr) 1999-03-25
JP2001516732A (ja) 2001-10-02
US6586613B1 (en) 2003-07-01
ES2242302T3 (es) 2005-11-01
AU9744298A (en) 1999-04-05
PT1017659E (pt) 2005-09-30
EP1017659B1 (fr) 2005-04-27

Similar Documents

Publication Publication Date Title
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
ID23374A (id) Halogenopirimidin
TR200102800T2 (tr) Yeni bileşikler.
NO963239D0 (no) Klorpyrimid-mellomprodukter
NO990544D0 (no) Substituerte pyrido- eller pyrimido-inneholdende 6,6 eller 6,7-bycykliske derivater
BG46598A3 (bg) Метод за получаване на алфа-хетероциклично заместени толунитрили
BR9612258B1 (pt) inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.
DK1200418T3 (da) Nematodicide trifluorbutener
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BR0012751A (pt) Benzofuranos serotonérgicos
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
ID27733A (id) Metoksiminofenilasetamida
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
AU6832498A (en) Substituted benzyl oximino compounds
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
BG102613A (en) New substituted imidazoles
WO2001005805A3 (fr) Nouveaux steroides substitues par halogene en c-19 de la serie androst-9(11)-ene, procedes permettant de les preparer et leur utilisation